Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data
Open Access
- 9 May 2017
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 102 (8) , 2798-2806
Abstract
Context Low levels of nonandrogenic anabolic hormones have been linked with frailty, but evidence is conflicting and prospective data are largely lacking. Objective To determine associations between nonandrogenic anabolic hormones and prospective changes in frailty status. Design/Setting A 4.3-year prospective observational study of community-dwelling men participating in the European Male Ageing Study. Participants Men (n = 3369) aged 40 to 79 years from eight European centers. Main Outcome Measures Frailty status was determined using frailty phenotype (FP; n = 2114) and frailty index (FI; n = 2444). Analysis Regression models assessed relationships between baseline levels of insulinlike growth factor 1 (IGF-1), its binding protein 3 (IGFBP-3), dehydroepiandrosterone sulfate (DHEA-S), 25-hydroxyvitamin D (25OHD), and parathyroid hormone (PTH), with changes in frailty status (worsening or improving frailty). Results The risk of worsening FP and FI decreased with 1 standard deviation higher IGF-1, IGFBP-3, and 25OHD in models adjusted for age, body mass index, center, and baseline frailty [IGF-1: odds ratio (OR) for worsening FP, 0.82 (0.73, 0.93), percentage change in FI, −3.7% (−6.0, −1.5); IGFBP-3: 0.84 (0.75, 0.95), −4.2% (−6.4, −2.0); 25OHD: 0.84 (0.75, 0.95); −4.4%, (−6.7, −2.0)]. Relationships between IGF-1 and FI were attenuated after adjusting for IGFBP-3. Higher DHEA-S was associated with a lower risk of worsening FP only in men >70 years old [OR, 0.57 (0.35, 0.92)]. PTH was unrelated to change in frailty status. Conclusions These longitudinal data confirm the associations between nonandrogenic anabolic hormones and the changes in frailty status. Interventional studies are needed to establish causality and determine therapeutic implications.Keywords
This publication has 37 references indexed in Scilit:
- FrailtyBiological Research For Nursing, 2012
- Serum 25‐Hydroxyvitamin D , Transitions Between Frailty States, and Mortality in Older Adults: The Invecchiare in Chianti StudyJournal of the American Geriatrics Society, 2012
- Circulating 25‐Hydroxyvitamin D Levels and Frailty in Older Men: The Osteoporotic Fractures in Men StudyJournal of the American Geriatrics Society, 2010
- Vitamin D deficiency and frailty in older AmericansJournal of Internal Medicine, 2010
- Sex Hormones and Frailty in Older Men: The Osteoporotic Fractures in Men (MrOS) StudyThe Journal of Clinical Endocrinology & Metabolism, 2009
- The association between dehydroepiandosterone and frailty in older men and womenAge and Ageing, 2009
- Association of Low Vitamin D Levels With the Frailty Syndrome in Men and WomenThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)Frontiers in Neuroendocrinology, 2009
- A standard procedure for creating a frailty indexBMC Geriatrics, 2008
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992